SCHEMBL7128903

SCHEMBL7128903

Oc1ccc(C(O)C(F)(F)F)cc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 8/20 0.48
RECQL P46063 7/20 0.48
MAPT P10636 7/20 0.48
KDM4E B2RXH2 7/20 0.48
APEX1 P27695 4/20 0.48
BLM P54132 4/20 0.48
KMT2A Q03164 4/20 0.48
LMNA P02545 3/20 0.48
MEN1 O00255 3/20 0.48
ADRB2 P07550 3/20 0.48
ADRA1A P35348 3/20 0.48
HPGD P15428 2/20 0.48
ADRB1 P08588 2/20 0.48
ADRA2A P08913 2/20 0.48
ADORA3 P0DMS8 2/20 0.48
ADRB3 P13945 2/20 0.48
DRD2 P14416 2/20 0.48
ADRA2B P18089 2/20 0.48
ADRA2C P18825 2/20 0.48
DRD1 P21728 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13885099 0.83 SHBG (0.47) TDP1RECQLMAPTKDM4EAPEX1
SCHEMBL7128359 0.82 TRPA1 (0.57) TDP1RECQLMAPTKDM4EAPEX1
SCHEMBL21488209 0.82 ESR1 (0.38) TDP1RECQLMAPTKDM4EAPEX1
SCHEMBL15538502 0.82 ESR1 (0.44) TDP1PTGS1
SCHEMBL9668811 0.80 TDP1 (0.50) TDP1RECQLMAPTKDM4EAPEX1
SCHEMBL15539085 0.79 RECQL (0.41) TDP1RECQLMAPTKDM4EAPEX1
SCHEMBL7128500 0.78 TDP1 (0.48) TDP1RECQLMAPTKDM4EAPEX1
SCHEMBL14593355 0.78 ESR1 (0.48) KDM4EALDH1A1NR1I2
SCHEMBL7125059 0.77 TUBB4A (0.55) TDP1MAPTBLMKMT2AMEN1
SCHEMBL15538836 0.77 ESR1 (0.47) TDP1KDM4EADRB2ADRB1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030144541-A1 Process for preparing alpha-halogenated retones RHODIA CHIMIE (FR) 2003-07-31 US claimed
EP-1250303-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2002-10-23 EP claimed
WO-2001055067-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2001-08-02 WO claimed
US-20030144541-A1 Process for preparing alpha-halogenated retones RHODIA CHIMIE (FR) 2003-07-31 US disclosed
EP-1250303-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2002-10-23 EP disclosed
WO-2001055067-A1 METHOD FOR PREPARING ALPHA-HALOGENATED KETONES RHODIA CHIMIE (FR) 2001-08-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144541-A1 Process for preparing alpha-halogenated retones ADH1A, ADH1C, RER1 TDP1 2515/4885RECQL 2273/4885MAPT 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.